Advertisement
Advertisement
OSRH
OSR Holdings, Inc. Common Stock
0.57
USDSponsored
-0.12
-17.45%
May 08, 15:59 UTC -4
Closed
After-Market
0.58
+0.01
+1.84%
OSRH Earnings Reports
Positive Surprise Ratio
OSRH beat 1 of 2 last estimates.
50%
Next Report
Date of Next Report
May 18, 2026
Estimate for Q1 26 (Revenue/ EPS)
$793.56K
/-$0.29
Implied change from Q4 25 (Revenue/ EPS)
+108.14%
/+81.25%
Implied change from Q1 25 (Revenue/ EPS)
--
/--
OSR Holdings, Inc. Common Stock earnings per share and revenue
On Mar 31, 2026, OSRH reported earnings of -0.16 USD per share (EPS) for Q4 25, missing the estimate of -0.10 USD, resulting in a -56.86% surprise. Revenue reached 381.27 thousand, compared to an expected 776.22 thousand, with a -50.88% difference. The market reacted with a -2.72% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 3 analysts forecast an EPS of -0.29 USD, with revenue projected to reach 793.56 thousand USD, implying an increase of 81.25% EPS, and increase of 108.14% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Natera, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.54
Actual
-$0.56
Surprise
-2.36%
Viatris Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.51
Actual
$0.59
Surprise
+15.17%
Charles River Laboratories International, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$1.96
Actual
$2.06
Surprise
+4.98%
Caris Life Sciences, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.02
Actual
$0.00
Surprise
+100.00%
Concentra Group Holdings Parent, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.34
Actual
$0.40
Surprise
+17.03%
Establishment Labs Holdings Inc.
Report Date
May 06, 2026 For Q1 26
Estimate
-$0.35
Actual
-$0.40
Surprise
-12.80%
Progyny, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.30
Actual
$0.50
Surprise
+63.99%
Omada Health, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.08
Actual
$0.01
Surprise
+112.22%
The Oncology Institute, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.02
Surprise
+74.46%
LifeMD, Inc. Common Stock
Report Date
May 06, 2026 For Q1 26
Estimate
-$0.22
Actual
-$0.20
Surprise
+12.85%
FAQ
What were OSR Holdings, Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, OSR Holdings, Inc. Common Stock reported EPS of -$0.16, missing estimates by -56.86%, and revenue of $381.27K, -50.88% below expectations.
How did the market react to OSR Holdings, Inc. Common Stock's Q4 2025 earnings?
The stock price moved down -2.72%, changed from $0.60 before the earnings release to $0.59 the day after.
When is OSR Holdings, Inc. Common Stock expected to report next?
The next earning report is scheduled for May 18, 2026.
What are the forecasts for OSR Holdings, Inc. Common Stock's next earnings report?
Based on 3
analysts, OSR Holdings, Inc. Common Stock is expected to report EPS of -$0.29 and revenue of $793.56K for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement